Adlai Nortye to Participate in Investor Conferences

viernes, 21 de noviembre de 2025, 8:01 am ET1 min de lectura
ANL--

Adlai Nortye, a clinical-stage biotech company, announced that its management team will participate in upcoming investor conferences. Members will give fireside chats and virtual presentations at the Evercore Healthcare Conference and Oppenheimer Annual Healthcare Life Sciences Conference. The company is focused on developing innovative cancer therapies, including next-generation immunotherapies and RAS-targeting therapies.

Adlai Nortye to Participate in Investor Conferences

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios